Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 100

1.

Immune complexes in ovarian cancer.

Poulton TA, Crowther ME, Hay FC, Nineham LJ.

Lancet. 1978 Jul 8;2(8080):72-3.

PMID:
78298
[PubMed - indexed for MEDLINE]
2.

Sequential studies of circulating immune complexes in gynecological malignancies.

Poulton TA, Crowther ME, Nineham LJ, Mooney NA, Hay FC.

Am J Reprod Immunol. 1982 Oct;2(5):265-9.

PMID:
7180950
[PubMed - indexed for MEDLINE]
3.

The value of the monoclonal antibody (cancer antigen 125) in serial monitoring of ovarian cancer: a comparison with circulating immune complexes.

Dodd J, Tyler JP, Crandon AJ, Blumenthal NJ, Fay RA, Baird PJ, Hicks LJ, Hudson CN.

Br J Obstet Gynaecol. 1985 Oct;92(10):1054-60.

PMID:
3863669
[PubMed - indexed for MEDLINE]
4.

[Sequential determination of circulating immune complexes in ovarian tumors].

Beaufort F, Auner H, Lahousen M.

Wien Med Wochenschr. 1986 Jul 15;136(13):317-22. German.

PMID:
3765649
[PubMed - indexed for MEDLINE]
5.

Detection of human ovarian tumor-associated antigens by antibodies isolated from ovarian carcinoma ascitic fluid.

Rao GS, Hanjani P.

Am J Obstet Gynecol. 1988 Jul;159(1):94-8.

PMID:
3394756
[PubMed - indexed for MEDLINE]
6.

Ovarian cancer-associated antibodies recovered from ascites: their use for the isolation of ovarian cancer-associated antigen to produce monoclonal antibodies.

Giancotti FR, Dorsett BH, Qian HN, Cronin WJ, Barber HR, Ioachim HL.

Gynecol Oncol. 1990 Apr;37(1):24-8.

PMID:
2182406
[PubMed - indexed for MEDLINE]
7.

The study of antibodies and antigens dissociated from the immune complexes extracted from ovarian carcinoma ascitic fluid.

Qian HN, Feng J, Fu TY.

Gynecol Oncol. 1985 Jan;20(1):100-8.

PMID:
3965372
[PubMed - indexed for MEDLINE]
8.

Activity of antibodies recovered from immune complexes of ovarian cancer patients.

Lutz PM, Dawson JR.

Cancer Immunol Immunother. 1984;17(3):180-9.

PMID:
6383602
[PubMed - indexed for MEDLINE]
9.

Immune complexes in ovarian cancer.

Clayton LA, Gall SA, Dawson JR, Creasman WT.

Gynecol Oncol. 1982 Apr;13(2):203-12. No abstract available.

PMID:
7076036
[PubMed - indexed for MEDLINE]
10.

An assessment of sequential measurements of immune complex levels in ovarian cancer patients with respect to clinical progress.

Mooney NA, Townsend PA, Wiltshaw E, Evans DG, Shanti-Raju K, Poulton TA.

Gynecol Oncol. 1983 Apr;15(2):207-13.

PMID:
6299906
[PubMed - indexed for MEDLINE]
11.

Circulating IgG-specific immune complexes as a potential tumor marker in gynecological malignancies.

Dodd JK, Hicks LJ, Tyler JP, Crandon AJ, Hudson CN.

Gynecol Oncol. 1983 Oct;16(2):232-9.

PMID:
6629124
[PubMed - indexed for MEDLINE]
12.

Application of polyethylene glycol turbidity assay to detection of circulating immune complexes in cancer patients.

Rayner AA, Steele G Jr, Rodrick ML, Harte PJ, Munroe AE, Zamcheck N, Wilson RE.

Am J Surg. 1981 Apr;141(4):460-4.

PMID:
6784583
[PubMed - indexed for MEDLINE]
13.

Analysis of sera from ovarian cancer patients for immune complexes.

Witkin SS, Bongiovanni AM, Armbruster T, Birnbaum S, Caputo T.

J Clin Lab Immunol. 1984 Jun;14(2):65-8.

PMID:
6748047
[PubMed - indexed for MEDLINE]
14.

Acute phase reactants and circulating immune complexes in patients with ovarian carcinoma.

Dobryszycka W, Gerber J, Zuwała-Jagiełło J, Ujec M.

Arch Immunol Ther Exp (Warsz). 1991;39(1-2):41-50.

PMID:
1725104
[PubMed - indexed for MEDLINE]
15.

Immune complexes in ovarian carcinoma.

Runowicz CD, Cohen CJ, Adelsberg BR.

Gynecol Oncol. 1989 Mar;32(3):350-3.

PMID:
2920956
[PubMed - indexed for MEDLINE]
16.

Immunotherapy of ovarian cancer with antibodies: a focus on oregovomab.

Berek JS.

Expert Opin Biol Ther. 2004 Jul;4(7):1159-65. Review.

PMID:
15268682
[PubMed - indexed for MEDLINE]
17.

Antibodies reactive with the protein core of MUC1 mucin are present in ovarian cancer patients and healthy women.

Richards ER, Devine PL, Quin RJ, Fontenot JD, Ward BG, McGuckin MA.

Cancer Immunol Immunother. 1998 Jul;46(5):245-52.

PMID:
9690452
[PubMed - indexed for MEDLINE]
18.
19.

Detection of malignant ovarian neoplasms: a review of the literature. III. Immunological detection and ovarian cancer-associated antigens.

Smith LH, Oi RH.

Obstet Gynecol Surv. 1984 Jun;39(6):346-60. Review.

PMID:
6203071
[PubMed - indexed for MEDLINE]
20.

Characteristics of immune complexes detectable by two independent assays in gynaecological malignancies.

Poulton TA, Mooney NA, Nineham LJ, Hay FC.

Clin Exp Immunol. 1983 Sep;53(3):573-80.

PMID:
6604605
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk